SCHEMBL8286356

SCHEMBL8286356

CCNC(=O)CSc1cc(C)nc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
RAB9A P51151 1/20 0.41
PDE11A Q9HCR9 1/20 0.40
PNP P00491 1/20 0.39
GAA P10253 2/20 0.38
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
TSHR P16473 1/20 0.38
MAPT P10636 1/20 0.37
TAS2R14 Q9NYV8 1/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287463 0.91 SMN1; SMN2 (0.48) HTTSMN1; SMN2GAAALDH1A1KDM4E
SCHEMBL8361765 0.90 GAA (0.45) SMN1; SMN2PDE11AGAAALDH1A1KDM4E
SCHEMBL8286357 0.87 ALDH1A1 (0.43) HTTSMN1; SMN2PDE11AALDH1A1KDM4E
SCHEMBL8286358 0.87 USP2 (0.46) HTTSMN1; SMN2PDE11APNPALDH1A1
SCHEMBL8286368 0.85 PDE11A (0.44) HTTSMN1; SMN2PDE11AGAAALDH1A1
SCHEMBL8361762 0.83 OPRK1 (0.41) HTTSMN1; SMN2RAB9APDE11AGAA
SCHEMBL8286408 0.82 RAB9A (0.41) CYP2C19HTTSMN1; SMN2RAB9APDE11A
SCHEMBL8287419 0.82 PDE11A (0.51) SMN1; SMN2PDE11AGAAALDH1A1KDM4E
SCHEMBL8286365 0.80 PDE11A (0.46) HTTSMN1; SMN2RAB9APDE11AGAA
SCHEMBL8286362 0.78 PDE7A (0.43) HTTPDE11AGAAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed